Target intelligence / Profile preview

Magnesium ion homeostasis pathway (Mg2+ homeostasis)

Target
Mg2+ homeostasis
Molecular classification
Ion channel, Transporter, Enzyme cofactor system
01

Overview

Magnesium ion homeostasis is the physiological process responsible for maintaining stable magnesium concentrations in the blood and tissues, which is vital for numerous cellular functions. This pathway is regulated through a balance of intestinal absorption, renal excretion, and mobilization from bone stores, primarily mediated by specific ion channels and transporters such as TRPM6, TRPM7, and SLC41A1 (de Baaij et al., 2015). Magnesium acts as an essential cofactor for over 300 enzymes, including those involved in ATP metabolism, DNA and RNA synthesis, and protein synthesis (NIH Office of Dietary Supplements). Disruptions in this pathway can lead to hypomagnesemia or hypermagnesemia, contributing to conditions like cardiovascular disease, type 2 diabetes, and neurological disorders (Romani, 2011). Pharmacological management typically involves magnesium supplementation or the adjustment of medications that impair magnesium handling, such as diuretics or proton pump inhibitors (William & Danziger, 2014). Understanding this pathway is crucial for managing electrolyte imbalances and their systemic consequences.

Other names
Magnesium metabolismMagnesium transport systemMg2+ regulationMagnesium handling
02

Mechanism of action

Drugs affecting this pathway act by supplementing systemic magnesium levels, inhibiting renal reabsorption in the thick ascending limb of Henle, or disrupting active transport in the gastrointestinal tract.

03

Biological functions

Ion transportEnzymatic cofactor regulationSignal transductionNeuromuscular functionBone mineralizationATP metabolism
04

Disease associations

HypomagnesemiaHypermagnesemiaCardiovascular diseaseType 2 diabetesMigrainePreeclampsiaGitelman syndrome
05

Safety considerations

Hypermagnesemia toxicityNeuromuscular blockadeCardiac arrhythmiasGastrointestinal distressRenal impairment risks
06

Interacting drugs

Magnesium sulfate

7 more in the full profile.

07

Biomarkers

Serum magnesium concentration24-hour urinary magnesium excretionFractional excretion of magnesium (FEMg)Intracellular magnesium levels

Beyond the preview

Go deeper on Magnesium ion homeostasis pathway (Mg2+ homeostasis).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magnesium ion homeostasis pathway (Mg2+ homeostasis).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call